NM_000238.4:c.1682C>T
Variant summary
Our verdict is Pathogenic. The variant received 23 ACMG points: 23P and 0B. PS3PM1PM2PM5PP2PP3_StrongPP5_Very_Strong
The NM_000238.4(KCNH2):c.1682C>T(p.Ala561Val) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000000684 in 1,461,748 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 13/23 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). ClinVar reports functional evidence for this variant: "SCV000234109: Published functional studies demonstrate a damaging effect as A561V leads to ion channel suppression (Kagan et al., 2000; Anderson et al., 2006; Li et al., 2007); SCV000283966: Experimental studies have shown that this missense change affects KCNH2 function (PMID:12354768, 16432067, 17445409, 23303164, 24623279).; SCV000737720: Functional studies indicate this alteration results in deficient protein trafficking and altered ion channel function (Anderson CL et al. Circulation. 2006;113:365-73; Jou CJ et al. Circ Res. 2013;112:826-30; Mehta A et al. Cardiovasc Res. 2014;102:497-506; Li G et al. Mol Med Rep. 2016;13:2467-75).; SCV004241648: Multiple studies have shown that this variant impairs normal protein function (examples : Anderson_2006, Li_2007, Jou_2013). PMID:7889573, 16432067, 17445409, 22949429, 24667783". Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A561T) has been classified as Pathogenic.
Frequency
Consequence
NM_000238.4 missense
Scores
Clinical Significance
Conservation
Publications
- long QT syndromeInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- long QT syndrome 2Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
- short QT syndromeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
- short QT syndrome type 1Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
- Brugada syndromeInheritance: AD Classification: MODERATE, NO_KNOWN Submitted by: ClinGen, Genomics England PanelApp
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 23 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000238.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| KCNH2 | MANE Select | c.1682C>T | p.Ala561Val | missense | Exon 7 of 15 | NP_000229.1 | A0A090N8Q0 | ||
| KCNH2 | c.1394C>T | p.Ala465Val | missense | Exon 5 of 13 | NP_001393682.1 | Q12809-7 | |||
| KCNH2 | c.1682C>T | p.Ala561Val | missense | Exon 7 of 9 | NP_742053.1 | Q12809-5 |
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| KCNH2 | TSL:1 MANE Select | c.1682C>T | p.Ala561Val | missense | Exon 7 of 15 | ENSP00000262186.5 | Q12809-1 | ||
| KCNH2 | TSL:1 | c.662C>T | p.Ala221Val | missense | Exon 3 of 11 | ENSP00000328531.4 | Q12809-2 | ||
| KCNH2 | TSL:1 | n.980C>T | non_coding_transcript_exon | Exon 3 of 5 |
Frequencies
GnomAD3 genomes Cov.: 34
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461748Hom.: 0 Cov.: 36 AF XY: 0.00 AC XY: 0AN XY: 727158 show subpopulations ⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
Age Distribution
GnomAD4 genome Cov.: 34
ClinVar
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at